Loading
Latest filing published 20 Mar 2024 for Kiromic Biopharma, Inc.. Read the official filing
No signal scores available.
Only one filing by Michael Catlin is known so far (20 March 2024): a share grant, in Kiromic Biopharma, Inc. That is too little to draw conclusions. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration